Tirzepatide - role in obesity, health and physical wellness. Information overview
Open Access
- 13 February 2025
- journal article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 38, 58191
Abstract
Nowadays there is an increasing number of people with overweight and obesity all around the world. Unhealthy food, sweets and fast foods are available everywhere, that causes self-perpetuating problem. Food restriction is an obvious treatment, but it is difficult to achieve. A certain solution are GLP-1 agonists using to treat type 2 diabetes. Last studies shown that that medicaments may be effective in promoting weight loss. Tirzepatide as a novelty and is a long-acting dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It can be very supportive in the fight against obesity.Keywords
This publication has 22 references indexed in Scilit:
- Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatideCPT: Pharmacometrics & Systems Pharmacology, 2024
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With ObesityJAMA, 2024
- Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trialNature Medicine, 2023
- Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trialThe Lancet, 2023
- Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development programObesity, 2022
- Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspectiveDiabetes, Obesity and Metabolism, 2022
- A systematic literature review on obesity: Understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesityComputers in Biology and Medicine, 2021
- The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical TrialsDiabetes Therapy, 2020
- Magnetic Resonance Imaging of Adipose Tissue in Metabolic DysfunctionRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2018
- Accuracy of body mass index in diagnosing obesity in the adult general populationInternational Journal of Obesity, 2008